Stock ANIP ANI PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News ANI Pharmaceuticals, Inc.

Equities

ANIP

US00182C1036

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-26 EDT 		5-day change 1st Jan Change
65.49 USD +2.03% Intraday chart for ANI Pharmaceuticals, Inc. +7.82% +18.77%
06-26 HC Wainwright Adjusts ANI Pharmaceuticals Price Target to $94 From $87, Maintains Buy Rating MT
06-24 Top Midday Gainers MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Adjusts ANI Pharmaceuticals Price Target to $94 From $87, Maintains Buy Rating
MT
ANI Pharmaceuticals’ CEO Nikhil Lalwani Named EY Entrepreneur Of The Year® 2024 New Jersey Award Winner
AQ
Top Midday Gainers
MT
Sector Update: Health Care Stocks Advance Premarket Monday
MT
Sector Update: Health Care
MT
US Equity Futures Mixed in Premarket Action as Traders Eye Friday's Inflation Data
MT
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Amid Uncertainty Ahead of Key Inflation Data
MT
Transcript : Alimera Sciences, Inc., ANI Pharmaceuticals, Inc. - M&A Call
Top Premarket Gainers
MT
ANI Pharmaceuticals : to Discuss Acquisition of Alimera Sciences Presentation
PU
ANI Pharmaceuticals to Acquire Alimera Sciences in $381 Million Deal
MT
ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences
AQ
ANI Pharmaceuticals, Inc. signed a definitive agreement to acquire Alimera Sciences, Inc. from Caligan Partners Master Fund LP and Caligan Partners Master Fund LP, managed by Caligan Partners, LP and others for approximately $300 million.
CI
Ani Pharmaceuticals Insider Sold Shares Worth $1,817,663, According to a Recent SEC Filing
MT
Ani Pharmaceuticals Insider Sold Shares Worth $317,900, According to a Recent SEC Filing
MT
ANI Pharmaceuticals Insider Sold Shares Worth $1,288,200, According to a Recent SEC Filing
MT
ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference
AQ
Ani Pharmaceuticals Insider Sold Shares Worth $794,568, According to a Recent SEC Filing
MT
Purcell & Lefkowitz LLP Announces Shareholder Investigation of ANI Pharmaceuticals, Inc. (NASDAQ: ANIP)
PR
ANI Pharmaceuticals Launches Kionex Suspension
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ANIP Stock
  4. News ANI Pharmaceuticals, Inc.